C4 Imaging receives top honors at the 5th annual Texas Life Science Forum

HOUSTON, June 6, 2016 /PRNewswire/ -- C4 Imaging LLC announced that it has been recognized as one of the Rice Alliance 10 Most Promising Life Science Companies at the 2016 Texas Life Science Forum hosted by the Rice Alliance for Technology and Entrepreneurship and BioHouston and Texas Healthcare and BioScience Institute at the BioScience Research Collaborative in Houston, May 26. The companies were chosen by industry experts and investors. More than 50 startup companies presented their business plan presentations at the forum. An additional six Nasdaq-listed life science companies provided status updates.

"This award, coming as it does from investors, entrepreneurs and business leaders in the Life Science community is an acknowledgement of the significant progress we've made towards commercialization of our unique C4 technology," said Andrew Bright, President and CEO of C4 Imaging. "It recognizes how we've successfully advanced through product development, regulatory approval to production and revenue generation. We're now poised to achieve approval for our second-generation products; these new products will serve significant patients populations in need of improved medical imaging options."

"Every year the quality of companies improves," said Rice Alliance Managing Director Brad Burke, who announced the winners at the event. "This year we had a diversity of companies, both in offerings as well as maturity. We highlighted 52 startups in addition to six more mature Nasdaq listed companies. These companies demonstrated the diversity of innovation, talent, investment, potential and success in life science industry."

The event is one of the largest life science venture capital conferences in the Southwest and featured more than 40 industry and investment speakers. Among the 500 attendees were venture capitalists and other investors, entrepreneurs, industry representatives, business leaders and service providers. 

About C4 IMAGING

C4 Imaging is a technology company focused on developing innovative medical devices that enable clinicians to more accurately perform image-guided procedures. C4 Imaging's patent portfolio is centered on its proprietary positive-signal MRI contrast agent (C4) and associated encapsulation technology.

C4 Imaging recently launched its first product, the Sirius™ MRI Marker. Sirius™ is the first commercially available positive-signal MRI Marker and is a permanently implantable medical device used in the management of prostate cancer. In prostate brachytherapy, Sirius™ MRI Markers are attached to radioactive seeds and inserted into the prostate. Physicians can view and evaluate seed placement utilizing MRI, allowing for a more accurate assessment of the quality of treatment.

C4 Imaging is actively developing multi-modality (MRI and CT) products that address significant opportunities outside of prostate cancer; with breast cancer biopsy and improved radiotherapy delivery being the next target markets.

For further information please contact:

Andrew Bright
President and CEO
C4 Imaging
Tel: 609 933 5895
[email protected]

Copyright © 2016.
Sirius is a trademark of C4 Imaging.

About The Rice Alliance for Technology and Entrepreneurship

The Rice Alliance for Technology and Entrepreneurship is Rice University's nationally recognized initiative devoted to the support of technology commercialization, entrepreneurship education and the launch of technology companies. It was formed as a strategic alliance of three Rice schools: the George R. Brown School of Engineering, the Wiess School of Natural Sciences and the Jesse H. Jones Graduate School of Business. Since inception in 1999, more than 1,700 early-stage companies have presented at the 170+ programs hosted by the Rice Alliance and raised more than $3.3 billion in funding.

About BioHouston

BioHouston, Inc. is a non-profit corporation founded by Houston area academic/research institutions.  We are leading a broad effort to establish the Houston region as a vigorous global competitor in life science and biotechnology commercialization.  Our mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization.  BioHouston's activities provide the greatest leverage in making the Houston region a world-class competitor in the life science industry.  All of our activities are designed to:  CONVENE people and organizations that need to come together to make the life science industry in Houston ignite, including scientists, intellectual property and product development experts, venture capitalists, pharmaceutical companies, and others.  COMMUNICATE and interact so that people and organizations can learn from one another, share information and explore opportunities.  CATALYZE the discoveries and commercial development so that the true potential of the life science industry in Houston can be unlocked.

SOURCE C4 Imaging

Related Links

http://www.c4imaging.com